Journal article icon

Journal article

A systematic review of neo-adjuvant radiotherapy in the treatment of breast cancer

Abstract:
Numbers of patients receiving exclusively NRT is small. However, NCRT is oncologically safe with a low side-effect profile including preceding breast reconstruction. Potential benefits include precise cancer volume targeting, chemosensitisation, elimination of delays in adjuvant therapies and alternatives to chemotherapy in oestrogen receptor positive patients. These factors warrant further exploration within randomised controlled-trials.
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Files:
Publisher copy:
10.3332/ecancer.2021.1175

Authors

More by this author
Role:
Author
ORCID:
0000-0002-4504-1354
More by this author
Role:
Author
ORCID:
0000-0001-8960-6049
More by this author
Institution:
University of Oxford
Role:
Author
ORCID:
0000-0003-2872-8514


Publisher:
Ecancer Global Foundation
Journal:
Ecancermedicalscience More from this journal
Volume:
15
Pages:
1175-1175
Publication date:
2021-01-22
DOI:
ISSN:
1754-6605


Language:
English
Keywords:
Pubs id:
1163953
Local pid:
pubs:1163953
Source identifiers:
W2769144434
Deposit date:
2026-02-13
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP